EGF Theramed Health Corp.
EVAHF
$0.07
-$0.01-12.50%
OTC PK
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, October 30, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
778 331 4303
Address
Pacific Centre
Suite 1600 - 609 Granville Street
PO Box 10068 Vancouver, BC V7Y 1C3
Suite 1600 - 609 Granville Street
PO Box 10068 Vancouver, BC V7Y 1C3
Country
Year Founded
--
Business Description
Sector
EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. It offers psychedelics for the treatment of conditions, such as...
more